ENDRA LIFE SCIENCES INC. Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price
ENDRA LIFE SCIENCES INC. (NDRA) reported Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price of $0.00 per share for the 6-month period ending 2025-06-30, per its 10-Q filed 2025-08-14.
Financial Statements › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice · last filed 2025-08-14
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2025-03-31 was $0.00, a 100.00% decline year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2024-03-31 was $2.06, a 48.76% decline year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2023-03-31 was $4.02, a 880.49% increase year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for the quarter ending 2022-03-31 was $0.41, a 70.07% decline year-over-year.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2024 was $3710.00, a 92188.56% increase from fiscal 2023.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2023 was $4.02, a 50.25% decline from fiscal 2022.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2022 was $8.08, a 242.37% increase from fiscal 2021.
- ENDRA LIFE SCIENCES INC. share-based compensation arrangements by share-based payment award, options, grants in period, weighted average exercise price for fiscal 2021 was $2.36, a 87.30% increase from fiscal 2020.
| Period end | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 3 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 6 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 9 month | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price 12 month |
|---|---|---|---|---|
| 2025-06-30 | $0.00 10-Q · filed 2025-08-14 | |||
| 2025-03-31 | $0.00 10-Q · filed 2025-05-15 | |||
| 2024-12-31 | $3710.00 10-K/A · filed 2025-04-07 | |||
| 2024-09-30 | $3710.00 10-Q/A · filed 2024-11-21 | |||
| 2024-06-30 | $2.06 10-Q · filed 2024-08-14 | |||
| 2024-03-31 | $2.06 10-Q · filed 2024-05-14 | |||
| 2023-12-31 | $4.02 10-K · filed 2024-03-28 | |||
| 2023-09-30 | $4.01 10-Q · filed 2023-11-14 | |||
| 2023-06-30 | $4.02 10-Q · filed 2023-08-14 | |||
| 2023-03-31 | $4.02 10-Q · filed 2023-05-15 | |||
| 2022-12-31 | $8.08 10-K · filed 2023-03-16 | |||
| 2022-09-30 | $0.41 10-Q · filed 2022-11-14 | |||
| 2022-06-30 | $0.41 10-Q · filed 2022-08-15 | |||
| 2022-03-31 | $0.41 10-Q · filed 2022-05-12 | |||
| 2021-12-31 | $2.36 10-K · filed 2022-03-30 | |||
| 2021-09-30 | $1.98 10-Q · filed 2021-11-15 | |||
| 2021-06-30 | $2.01 10-Q · filed 2021-08-12 | |||
| 2021-03-31 | $1.37 10-Q · filed 2021-05-17 | |||
| 2020-12-31 | $1.26 10-K · filed 2021-03-25 | |||
| 2020-09-30 | $1.53 10-Q · filed 2020-11-16 | |||
| 2020-06-30 | $0.24 10-Q · filed 2020-08-14 | |||
| 2020-03-31 | $0.24 10-Q · filed 2020-05-14 | |||
| 2019-12-31 | $1.13 10-K · filed 2020-03-26 | |||
| 2019-09-30 | $2.05 10-Q · filed 2019-11-13 | |||
| 2019-06-30 | $2.05 10-Q · filed 2019-08-08 | |||
| 2019-03-31 | $2.85 10-Q · filed 2019-05-14 | |||
| 2018-12-31 | $2.58 10-K · filed 2019-03-11 | |||
| 2018-09-30 | $4.44 10-Q · filed 2018-11-05 | |||
| 2018-06-30 | $4.44 10-Q · filed 2018-08-13 | |||
| 2018-03-31 | $4.44 10-Q · filed 2018-05-15 | |||
| 2017-12-31 | $4.91 10-K · filed 2018-03-20 | |||
| 2017-09-30 | $4.93 10-Q · filed 2017-11-14 | |||
| 2017-06-30 | $4.94 10-Q · filed 2017-08-07 | |||
| 2017-03-31 | $0.00 10-Q · filed 2017-06-21 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |